CN1042424C - 将二水合罗拉卡转变成一水合罗拉卡的方法 - Google Patents

将二水合罗拉卡转变成一水合罗拉卡的方法 Download PDF

Info

Publication number
CN1042424C
CN1042424C CN94106984A CN94106984A CN1042424C CN 1042424 C CN1042424 C CN 1042424C CN 94106984 A CN94106984 A CN 94106984A CN 94106984 A CN94106984 A CN 94106984A CN 1042424 C CN1042424 C CN 1042424C
Authority
CN
China
Prior art keywords
monohydrate
dihydrate
temperature
loracarbef
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94106984A
Other languages
English (en)
Chinese (zh)
Other versions
CN1097754A (zh
Inventor
E·F·普罗查塞克
E·E·施特劳斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1097754A publication Critical patent/CN1097754A/zh
Application granted granted Critical
Publication of CN1042424C publication Critical patent/CN1042424C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CN94106984A 1993-06-04 1994-06-03 将二水合罗拉卡转变成一水合罗拉卡的方法 Expired - Fee Related CN1042424C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US071,550 1993-06-04
US08/071,550 US5374719A (en) 1993-06-04 1993-06-04 Process for converting loracarbef dihydrate to loracarbef monohydrate
US071550 1993-06-04

Publications (2)

Publication Number Publication Date
CN1097754A CN1097754A (zh) 1995-01-25
CN1042424C true CN1042424C (zh) 1999-03-10

Family

ID=22102051

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94106984A Expired - Fee Related CN1042424C (zh) 1993-06-04 1994-06-03 将二水合罗拉卡转变成一水合罗拉卡的方法

Country Status (29)

Country Link
US (1) US5374719A (2)
EP (1) EP0627430B1 (2)
JP (1) JP3442479B2 (2)
KR (1) KR100311699B1 (2)
CN (1) CN1042424C (2)
AT (1) ATE146472T1 (2)
AU (1) AU678000B2 (2)
BR (1) BR9402149A (2)
CA (1) CA2125001C (2)
CO (1) CO4230100A1 (2)
CZ (1) CZ283468B6 (2)
DE (1) DE69401163T2 (2)
DK (1) DK0627430T3 (2)
ES (1) ES2097002T3 (2)
FI (1) FI108132B (2)
GR (1) GR3022111T3 (2)
HU (1) HU217066B (2)
IL (1) IL109871A (2)
MY (1) MY110724A (2)
NO (1) NO306302B1 (2)
NZ (1) NZ260653A (2)
PE (1) PE13195A1 (2)
PH (1) PH30304A (2)
PL (1) PL174539B1 (2)
RU (1) RU2124013C1 (2)
TW (1) TW252980B (2)
UA (1) UA27812C2 (2)
YU (1) YU33394A (2)
ZA (1) ZA943827B (2)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
CA2483241C (en) * 2002-04-29 2011-05-31 Actelion Pharmaceuticals Ltd Novel diazabicyclononene derivatives
US20070225285A1 (en) * 2005-11-04 2007-09-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311366A1 (en) * 1987-10-06 1989-04-12 Eli Lilly And Company Crystalline beta-lactam hydrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311366A1 (en) * 1987-10-06 1989-04-12 Eli Lilly And Company Crystalline beta-lactam hydrate

Also Published As

Publication number Publication date
FI942633A0 (fi) 1994-06-03
GR3022111T3 (en) 1997-03-31
BR9402149A (pt) 1994-12-27
FI942633L (fi) 1994-12-05
NO306302B1 (no) 1999-10-18
ZA943827B (en) 1995-12-01
CN1097754A (zh) 1995-01-25
CA2125001C (en) 2004-08-03
KR950000701A (ko) 1995-01-03
TW252980B (2) 1995-08-01
AU6451694A (en) 1994-12-08
HUT67743A (en) 1995-04-28
CZ283468B6 (cs) 1998-04-15
CA2125001A1 (en) 1994-12-05
JPH06345763A (ja) 1994-12-20
NZ260653A (en) 1995-12-21
ES2097002T3 (es) 1997-03-16
HU9401675D0 (en) 1994-09-28
PE13195A1 (es) 1995-05-24
CZ134294A3 (en) 1994-12-15
DE69401163D1 (de) 1997-01-30
FI108132B (fi) 2001-11-30
PL303676A1 (en) 1994-12-12
AU678000B2 (en) 1997-05-15
PL174539B1 (pl) 1998-08-31
CO4230100A1 (es) 1995-10-19
DE69401163T2 (de) 1997-04-30
PH30304A (en) 1997-02-20
KR100311699B1 (ko) 2001-12-28
DK0627430T3 (da) 1997-06-02
EP0627430A1 (en) 1994-12-07
ATE146472T1 (de) 1997-01-15
YU33394A (sh) 1996-10-18
EP0627430B1 (en) 1996-12-18
HU217066B (hu) 1999-11-29
US5374719A (en) 1994-12-20
JP3442479B2 (ja) 2003-09-02
NO942048D0 (no) 1994-06-02
IL109871A (en) 1998-08-16
UA27812C2 (uk) 2000-10-16
RU2124013C1 (ru) 1998-12-27
MY110724A (en) 1999-01-30
NO942048L (no) 1994-12-05
IL109871A0 (en) 1994-10-07
RU94019424A (ru) 1996-04-20

Similar Documents

Publication Publication Date Title
EP1337525B1 (en) Process for the crystallization of (r)- or (s)-lansoprazole
CN1064680C (zh) 奥美拉唑镁的制备方法
DE60131649T2 (de) Verfahren zur herstellung eines kristalls
US5880289A (en) Crystallization method
HRP931429A2 (en) Process for the preparation of amlodipin benzensulfonate
SK17012002A3 (sk) Hydrochlorid kyseliny alfa,alfa-dimetyl-4-{1-hydroxy-4-{4- (hydroxydifenylmetyl)-1-piperidinyl}butyl}benzénoctovej, jeho kryštálová modifikácia a spôsob prípravy tejto modifikácie
KR100311699B1 (ko) 로라카베프이수화물을로라카베프일수화물로전환시키는방법
CA2178369C (en) Process for the purification and crystallisation of iopamidol
KR100308746B1 (ko) 로라카베프이소프로판올레이트및로라카베프이소프로판올레이트를로라카베프일수화물로전환시키는방법
EP1243594B1 (en) Process for crystallizing N2-((S)-1-ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysyl-L-proline
CN1053794A (zh) 两性霉素b的纯化方法与组合物
EP1189913A1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
US3947415A (en) Cefamandole derivatives
FI75169B (fi) Foerfarande foer framstaellning av kristallint natriumcefoperazon.
CN1023703C (zh) 拆分顺式3-氨基-4[2-(2-呋喃基)乙-1-基]-1-甲氧羰基甲基-氮杂环丁-2-酮的方法
US4353918A (en) Dextrorotatory bicyclic thiadiaza compounds and pharmaceutical preparations containing them
JPH08239381A (ja) 安定なベンズイミダゾール誘導体金属塩の溶媒和物及びその製造法並びにそれを含有する抗潰瘍剤
IE51399B1 (en) Solvate of amoxicillin,process for the preparation thereof and process for the preparation of injectable preparations from this solvate
US4370485A (en) Germaazaspirodiones
JP2001300293A (ja) 無機無水物または有機無水物の製造法
CA1089447A (en) Sodium cefamandole crystalline forms
EP1730153A1 (en) Isopropanol water solvate of olanzapine
CN1204329A (zh) (2R,3S)－3－叔丁氧基羰基氨基－2－羟基-3-苯基丙酸紫杉－11－烯－13α－酯二水合物及其制备方法
CN1200123A (zh) 水合物结晶及其制备方法
JPH0135820B2 (2)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee